主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OPK
#2158
Opko Health Inc.
1.2
0
+1.69%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.69%
每月变动
-6.98%
6个月变化
-15.49%
年变化
-28.99%
前一天收盘价
1.1
8
Open
1.2
0
Bid
Ask
Low
1.2
0
High
1.2
0
交易量
105
市场
股票
医疗保健
OPK
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
2.47 B
2.4 B
2.17 B
2.01 B
2.2 B
1.93 B
Total liabilities
801.51 M
714.59 M
605.61 M
622.48 M
834.76 M
663.99 M
Total equity
1.67 B
1.69 B
1.56 B
1.39 B
1.37 B
1.27 B
Total liabilities & shareholders' equities
2.47 B
2.4 B
2.17 B
2.01 B
2.2 B
1.93 B
Total debt
—
—
—
—
—
—
Net debt
—
—
—
—
—
—
Opko Health Inc
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
新闻
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript
OPKO HealthQ4每股收益及营收超出预期
Opko Health earnings beat by $0.03, revenue topped estimates
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
H.C. Wainwright重申Opko Health股票买入评级
Opko Health stock rating reiterated at Buy by H.C. Wainwright
OPKO和Entera扩大合作开发口服PTH治疗方案
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth